Twist Bioscience Corp announced it raised $2.65 Million in an initial filing from an offering of $2.65 Million
Twist Bioscience Corp announced it raised $2.65 Million in an initial filing from an offering of $2.65 Million
04/19/16, 4:07 PM
Location
Money raised
$2.65 million
Industry
biotechnology
Round Type
seed
Company Info
Location
455 mission bay boulevard south
san francisco, california, united states
Additional Info
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn | YouTube